European Archives - Page 350 of 1541 - European Medical Journal

Iron Deficiency Without Anaemia Linked to Brain Changes in Teenagers

A new study has found that iron deficiency (ID) without anaemia may impact brain development in adolescents….

Thyroid Hormones Linked to Gestational Diabetes Risk

Low thyroid hormone levels may increase gestational diabetes risk, with isolated hypothyroxinaemia showing the strongest association.

Immunotherapy Combo Shows Promise in Lung Cancer

The BTCRC LUN 16-081 trial is the first to evaluate a shorter, six-month course of consolidation immunotherapy using nivolumab alone or in combination with ipilimumab.

Ketamine Reduces Inflammation After Liver Resection

The study explored the anti-inflammatory and analgesic effects of low-dose ketamine and Dex, both commonly used anaesthetic agents with known immune-modulating properties.

Ear-Clip Device Boosts Fitness in Adults via Vagus Nerve Stimulation

Vagus nerve stimulation significantly boosts fitness and reduces inflammation, UK trial finds. Discover if it could benefit you.

New Drug Pairing Offers Hope for Advanced Skin Lymphoma

A new combination treatment may offer a promising option for patients with relapsed or refractory cutaneous T-cell lymphoma….

Home-Based Brain Stimulation Reduces Pain and Disability in Fibromyalgia

A randomised trial finds that home-based brain stimulation plus exercise and education reduces pain-related disability in fibromyalgia patients, even among placebo responders.

Doxycycline After Sex Significantly Reduces Bacterial STI Risk

Taking doxycycline after condomless sex significantly reduced bacterial STIs in men who have sex with men and transgender women.

Colourful arrows going in different directions on a grey background

FDA and NICE: two leaders step down in same week

Two major health agencies are facing leadership reshuffles, with the resignations of the FDA’s Vinay Prasad and NICE’s Dr Sam Roberts.

HPV Vaccine Significantly Reduces Actinic Keratosis Lesions

Results from the 12-month double-blind, placebo-controlled trial revealed that the vaccinated group consistently experienced greater reductions in AK lesions than the control group.